Manufacture Joint Stock

Vinbiocare is a biotechnology company based in Vietnam and a subsidiary of Vingroup, the country's largest conglomerate. Established in 2021, the company focuses on the research, development, and large-scale manufacturing of vaccines and biological products. It gained international prominence through a strategic partnership with Arcturus Therapeutics to establish a state-of-the-art manufacturing facility in Hanoi for mRNA-based COVID-19 vaccines, specifically ARCT-154. The company's facility is designed to meet international GMP standards and has the capacity to produce hundreds of millions of doses annually. Beyond pandemic response, Vinbiocare aims to leverage its mRNA technology platform to develop and manufacture a broader range of pharmaceuticals and biological treatments for the Southeast Asian market.